Inventor · disambiguated record
Fred Widmer
Also filed as: WIDMER FRED
11 granted patents·352 citations·filing 1980–1999
92Inventor score
Files withPEPTIDE TECHNOLOGY LTD4CARLBIOTECH LTD AS2CARLSBERG BIOTECHNOLOGY LTD2ADVANCED IMMUNI T INC1ADVANCED IMMUNIT INC1
Top patents by PatentIndex Score
11 records- 0185US6262119B1Methods of treating immunopathologies using polyunsaturated fatty acidsPEPTIDE TECHNOLOGY LTD·Filed 1997·Granted Jul 17, 2001·77 cites·13 claims
- 0282US5411942APeptide derivative, pharmaceutical preparation containing it and method for treatment of glaucomaCARLBIOTECH LTD AS·Filed 1990·Granted May 2, 1995·72 cites·3 claims
- 0377US5756449APeptide T and related peptides in the treatment of inflammation, including inflammatory bowel diseasePEPTIDE TECHNOLOGY LTD·Filed 1993·Granted May 26, 1998·63 cites·18 claims
- 0475US4339534AProcess for enzymatic production of peptidesFORENEDE BRYGGERIER AS·Filed 1980·Granted Jul 13, 1982·33 cites·13 claims
- 0568US4806473AProcess for enzymatic production of peptidesCARLSBERG BIOTECHNOLOGY LTD·Filed 1985·Granted Feb 21, 1989·21 cites·12 claims
- 0664US6011014APeptide T and related peptides in the treatment of inflammation, including multiple sclerosisADVANCED IMMUNIT INC·Filed 1998·Granted Jan 4, 2000·15 cites·17 claims
- 0761US5998476ASynthetic polyunsaturated fatty acid analoguesPEPTIDE TECHNOLOGY LTD·Filed 1995·Granted Dec 7, 1999·18 cites·8 claims
- 0860US6265374B1Peptide T and related peptides in the treatment of inflammation, including multiple sclerosisADVANCED IMMUNI T INC·Filed 1999·Granted Jul 24, 2001·12 cites·17 claims
- 0947US5795859APeptide which abrogates TNF and/or LPS toxicityPEPTIDE TECHNOLOGY LTD·Filed 1992·Granted Aug 18, 1998·16 cites·6 claims
- 1047US5464821ASmall peptidic compounds useful for the treatment of glaucomaCARLBIOTECH LTD AS·Filed 1992·Granted Nov 7, 1995·16 cites·9 claims
- 1147US4645740AProcess for enzymatic replacement of the B-30 amino acid in insulinsCARLSBERG BIOTECHNOLOGY LTD·Filed 1981·Granted Feb 24, 1987·9 cites·12 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →